Real-world data study describes therapy patterns in amyotrophic lateral sclerosis, highlighting determinants of riluzole use.
The purpose was to describe the use patterns of pharmacological and non-pharmacological therapies and investigate potential determinants of riluzole use in patients newly diagnosed with amyotrophic lateral sclerosis (ALS) in three Italian regions.
No takes yet. Share an insight, caveat, or question.
Paoletti et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: